EPISODE · Jul 29, 2021 · 24 MIN
A conversation with Sarah Boyce, CEO of Avidity Biosciences
from MedCity Pivot · host Arundhati Parmar, Sarah Boyce
Arundhati interviewed Sarah Boyce, CEO of Avidity Biosciences. In October 2019, Sarah Boyce joined Avidity as President and CEO, and she serves as a member of the board of directors. Ms. Boyce brings to Avidity extensive operational, commercial and leadership experience in the life sciences industry and has built global organizations, bringing a number of innovative therapies including Tegsedi®, Waylivra®, Soliris®, Gleevec® and Tasigna® to patients. Episode Resources Connect with Arundhati Parmar [email protected] https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Sarah Boyce https://www.linkedin.com/in/sarah-boyce-7775808/ http://www.aviditybiosciences.com/about-us/
NOW PLAYING
A conversation with Sarah Boyce, CEO of Avidity Biosciences
No transcript for this episode yet
Similar Episodes
Jun 23, 2026 ·61m
Jun 19, 2026 ·66m
Jun 16, 2026 ·63m
Jun 12, 2026 ·61m
Jun 9, 2026 ·71m